ANDERA PARTNERS: 13F holdings
CIK 17572832026Q2
| Positions | 8 |
|---|
| Reported value | $206.5m |
|---|
| Filed | 2026-07-22 |
|---|
Change since last quarter
| Positions | 8 (+1 vs prior quarter) |
|---|
| Reported value | $206.5m (+16.7%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| KESTRA MED TECHNOLOGIES LTD | 2,728,679 | $69.4m | 33.6% |
| MLYS MINERALYS THERAPEUTICS INC | 1,591,917 | $42.9m | 20.8% |
| AVALYN PHARMACEUTICALS INC | 929,824 | $30.6m | 14.8% |
| AGOMAB THERAPEUTICS NV | 1,538,702 | $20.0m | 9.7% |
| EVOMMUNE INC | 1,391,990 | $18.5m | 9.0% |
| INVENTIVA SA | 3,633,181 | $13.7m | 6.7% |
| ABVX ABIVAX SA | 78,125 | $10.4m | 5.0% |
| NYXOAH S A | 522,057 | $882,276 | 0.4% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1757283")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples